Phentermine
Back to searchMolecule Structure
Scientific Name
Phentermine
Description of the Drug
Phentermine is a sympathomimetic anorectic agent used as a short-term adjunct therapy that is included in a regimen of weight reduction in cases of exogenous obesity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00191
http://www.drugbank.ca/drugs/DB00191
Brand Name(s)
Duromine, Ionamin, Phentermine resin 30, Phentermine resin complex
Company Owner(s)
Vitarine Pharmaceuticals Inc, Glaxosmithkline, Sun Pharmaceutical Industries Inc, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Elite Laboratories Inc, Sandoz Consumer Health Care Group Div Sandoz Pharmaceuticals Corp, Citius Pharmaceuticals Llc, Mm Mast And Co, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Norepinephrine transporter | SINGLE PROTEIN | RELEASING AGENT | CHEMBL222 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL26615 | ||||
| PharmGKB | PA164748099 | ||||
| Human Metabolome Database | HMDB0014337 | ||||
| DrugBank | DB00191 | ||||
| PubChem: Thomson Pharma | 15194700 | ||||
| PubChem | 4771 | ||||
| Mcule | MCULE-1315767006 | ||||
| NMRShiftDB | 20143233 | ||||
| LINCS | LSM-4174 | ||||
| Nikkaji | J5.348A | ||||
| BindingDB | 50246598 | ||||
| EPA CompTox Dashboard | DTXSID9023461 | ||||
| DrugCentral | 2140 | ||||
| Brenda | 5837 | ||||
| Guide to Pharmacology | 7269 | ||||
| rxnorm | PHENTERMINE RESIN | LOMAIRA | PHENTERMINE | PHENTERMINE HYDROCHLORIDE | ADIPEX-P |
| KEGG Ligand | C07438 | ||||
| ChEBI | 8080 | ||||
| ZINC | ZINC000008403947 |
